Withdrawal of AGM Resolutions 10 and 11

Inspiration Healthcare Group PLC

20 July 2026

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Group" or the "Company")

Withdrawal of AGM Resolutions 10 and 11

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, pioneering, specialist neonatal intensive care medical devices, advises that the Board has withdrawn Resolutions 10 and 11 from the agenda of the Annual General Meeting ("AGM") of the Company's shareholders scheduled to be held at 12:00 p.m. (UK time) on 23 July 2026 at the Company's registered office, Unit 7/8 Commerce Park, Commerce Way, Croydon, England CR0 4YL.

Resolutions 10 and 11 were special resolutions relating to the disapplication of pre-emption rights in respect of the allotment of equity securities for cash, and the renewal of the Company's authority to make market purchases of its own ordinary shares, respectively. Whilst the Board considers the flexibility afforded by these authorities to be in the best interests of the Company, it has taken the decision to withdraw Resolutions 10 and 11 from the agenda of the AGM following feedback received from a significant shareholder in the Company since the publication of the notice of the AGM.

The withdrawal of Resolutions 10 and 11 does not affect the validity of the notice of the AGM, the proxy form or any votes submitted in respect of the remaining resolutions to be proposed at the AGM. Arrangements for the AGM are unchanged from those previously notified, as is the numbering of all other proposed resolutions at the AGM.

Also, the withdrawal of these Resolutions does not affect the strategy or day-to-day running of the business, and the Directors do not currently envisage that the Company would need to exercise the authorities that would have been granted by Resolutions 10 and 11 before the Company's next annual general meeting. Should such need arise, a separate general meeting would be convened to seek shareholder approval at the relevant time.

For further information, please contact:

Inspiration Healthcare Group plc				Tel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer Alan Olby, Chief Financial Officer

Singer Capital Markets (Nominated Adviser & Broker)					Tel: +44 (0)20 3100 2000
Alex Bond
Jalini Kalaravy

Cavendish Capital Markets (Joint Broker)			Tel: + 44 (0)20 7220 0500
Giles Balleny / Joe Smith
Nigel Birks
Harriet Ward

Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
Anna Dunphy		Mob: +44 (0) 7876 741 001
Rachel Broad		Mob: +44 (0) 7747 515 393

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END